A diagnosis of Polycystic Ovary Syndrome (PCOS), sometimes called PCOD, can bring many questions. Why are your periods irregular? Is weight gain related to your hormones? Will you need fertility treatment to become pregnant?
The most important thing to understand is that having PCOS does not mean you cannot have a baby. Many women with PCOS conceive naturally, while others benefit from ovulation induction or assisted reproductive treatments.
At Life Fertility Centre, South Mumbai, Dr. Katha Desai provides individualised PCOS evaluation and fertility treatment based on your hormonal health, metabolic profile, menstrual patterns and pregnancy goals.
From identifying ovulation difficulties to planning fertility treatment, the focus is on understanding the underlying condition and choosing the least invasive effective treatment appropriate for your circumstances.
Polycystic Ovary Syndrome (PCOS) is a common hormonal and metabolic condition affecting women of reproductive age. It may interfere with regular ovulation, menstrual cycles, androgen hormone levels and metabolic health.
PCOS can affect fertility because the ovaries may not release an egg regularly. This is known as oligo-ovulation or anovulation.
However, PCOS affects individuals differently. Some women have irregular periods and noticeable symptoms, while others have relatively mild symptoms.
Importantly, polycystic-appearing ovaries on ultrasound alone do not establish a diagnosis of PCOS.
The terms PCOD (Polycystic Ovarian Disease) and PCOS (Polycystic Ovary Syndrome) are frequently used interchangeably in India.
PCOD is sometimes described informally as a milder ovarian condition, while PCOS is described as a broader hormonal and metabolic disorder. However, PCOD is not a separate, internationally standardised diagnosis with established criteria distinct from PCOS.
Clinicians should therefore evaluate symptoms and laboratory findings rather than assuming that a diagnosis labelled PCOD is necessarily milder.
| Feature | PCOD (common informal usage) | PCOS (recognised clinical diagnosis) |
|---|---|---|
| Medical terminology | Commonly used in India | Internationally recognised syndrome |
| Diagnostic criteria | No separate universally accepted criteria | Established evidence-based diagnostic criteria |
| Menstrual irregularity | May be present | Common, but not universal |
| Elevated androgens | May be present | One of the diagnostic features |
| Insulin resistance | Possible | Common, but not required for diagnosis |
| Fertility difficulties | May occur | May occur due to irregular ovulation |
| Management | Based on actual symptoms and findings | Individualised hormonal, metabolic and reproductive care |
Both terms should prompt an appropriate medical evaluation rather than unnecessary worry.
In adults, PCOS is generally diagnosed when at least two of the following three features are present, after excluding other conditions that may cause similar symptoms:
Irregular, infrequent or absent menstrual periods may indicate that ovulation is not occurring consistently.
Elevated androgen activity may cause excessive facial or body hair, acne or scalp hair thinning. Blood tests can help assess androgen levels when indicated.
Ultrasound may show an increased number of small ovarian follicles or increased ovarian volume. In adults, appropriately measured anti-Müllerian hormone (AMH) may sometimes be used as an alternative to ultrasound within the diagnostic algorithm.
In adolescents, diagnostic requirements are different: both irregular menstrual cycles, interpreted according to time since menarche, and hyperandrogenism are required. Ultrasound and AMH are not recommended for diagnosing PCOS in adolescents.
PCOS is a complex condition involving genetic, hormonal, ovarian and metabolic factors. There is no single cause that explains every case.
Insulin helps regulate blood glucose levels. In many women with PCOS, the body's cells respond less effectively to insulin, leading to increased insulin production.
Elevated insulin levels may contribute to increased ovarian androgen production and disrupted ovulation.
However, insulin resistance is not present in every patient with PCOS, and PCOS can occur at any body weight.
Androgens are hormones naturally present in women. In PCOS, androgen levels or activity may be elevated, contributing to acne, excessive facial hair and irregular ovulation.
Luteinising hormone (LH) and follicle-stimulating hormone (FSH) regulate ovarian follicle development and ovulation.
Some women with PCOS have altered LH secretion or an increased LH-to-FSH ratio. However, the LH:FSH ratio is not a reliable standalone diagnostic test for PCOS.
In some women with PCOS, ovarian follicles begin developing but do not consistently mature and release an egg.
This can result in irregular menstrual cycles and difficulty predicting the fertile window.
Treatment may help restore or induce ovulation when pregnancy is desired.
Symptoms vary considerably between individuals.
PCOS can also be associated with sleep apnoea, dyslipidaemia and increased long-term metabolic risk.
Yes. Many women with PCOS conceive naturally, particularly when ovulation occurs regularly or intermittently.
Others may require treatment to improve ovulation frequency.
The chances of pregnancy depend on several factors, including age, ovarian function, sperm quality, fallopian tube health and the presence of other reproductive conditions.
A PCOS diagnosis alone does not determine whether IVF will be necessary.
At Life Fertility Centre, fertility treatment planning begins by assessing the couple's overall reproductive health and identifying the most appropriate next step.
PCOS treatment should be tailored to your symptoms, metabolic health and fertility goals. Not every woman with PCOS needs medication, and not everyone experiencing difficulty conceiving needs IVF.
The first step is understanding your menstrual history, symptoms, metabolic health and reproductive goals.
Depending on your clinical findings, investigations may include:
| Investigation | Clinical purpose |
|---|---|
| Pelvic ultrasound | Assess ovarian morphology and reproductive anatomy |
| AMH | Assess ovarian reserve in fertility planning or support adult PCOS diagnosis when appropriate |
| Total/free testosterone | Evaluate biochemical hyperandrogenism |
| TSH and prolactin | Exclude selected alternative causes of menstrual irregularity |
| LH and FSH | Assess reproductive hormonal function in selected cases |
| 75-g oral glucose tolerance test (OGTT) | Evaluate glucose tolerance and diabetes risk |
| Lipid profile | Assess cholesterol and cardiovascular risk factors |
| Blood pressure and BMI | Evaluate general cardiometabolic health |
Important: Fasting insulin measurements and the LH:FSH ratio are not recommended as routine diagnostic tests for PCOS. The 75-g OGTT is the most accurate recommended test for assessing glycaemic status in PCOS, including when planning pregnancy.
Healthy lifestyle measures are important for all women with PCOS, regardless of body weight.
Treatment may include:
There is no single diet proven to be superior for every woman with PCOS. Restrictive dieting is not necessary, and treatment should avoid weight-related stigma.
Metformin may be considered for selected patients, particularly when metabolic indications are present. It can also have a role in some fertility treatment plans, although it is not the most effective first-line ovulation-inducing medication.
For women who are not ovulating regularly and wish to conceive, ovulation induction may be recommended.
| Feature | Letrozole | Clomiphene citrate |
|---|---|---|
| Purpose | Stimulates follicle development and ovulation | Stimulates ovulation |
| Guideline position | Preferred first-line medication for anovulatory PCOS infertility when no other infertility factors exist | Alternative option |
| Monitoring | Ultrasound monitoring as indicated | Ultrasound monitoring as indicated |
| Important considerations | Pregnancy must be excluded before treatment; local regulatory status should be checked | Multiple pregnancy risk and potential effects on endometrium |
The 2023 International Evidence-based PCOS Guideline recommends letrozole as the first-line pharmacological treatment for anovulatory infertility in women with PCOS and no other infertility factors.
Ultrasound scans help assess follicle development and guide the timing of intercourse or further fertility treatment.
If oral medication is unsuccessful, carefully monitored gonadotropin injections may be considered.
Gonadotropins require particular caution in women with PCOS because multiple follicles may develop, increasing the risk of multiple pregnancy and ovarian hyperstimulation.
When ovulation induction alone is unsuccessful, or additional fertility factors are present, assisted reproductive treatments may be considered.
IUI involves placing prepared sperm into the uterus around the time of ovulation.
It may be appropriate when fallopian tubes are patent, sperm parameters are suitable and the overall fertility assessment supports its use.
IUI is not automatically required simply because a woman has PCOS.
IVF may be recommended when first- or second-line ovulation induction treatments have failed or when another fertility condition makes IVF appropriate.
During IVF, eggs are retrieved from the ovaries, fertilised in the laboratory and cultured into embryos before transfer or cryopreservation.
Women with PCOS may respond strongly to ovarian stimulation, making individualised medication dosing and careful monitoring particularly important.
Ovarian Hyperstimulation Syndrome (OHSS) is a potential complication of ovarian stimulation.
Women with PCOS may have an increased risk because their ovaries can produce a high number of developing follicles.
Modern risk-reduction strategies include:
These strategies reduce risk but cannot guarantee that OHSS will not occur.
Following a freeze-all cycle, suitable embryos can be warmed and transferred after the ovaries have recovered and the uterine lining has been prepared.
Frozen embryo transfer may be particularly helpful when fresh transfer is postponed because of OHSS risk.
However, freezing all embryos is not necessary for every woman with PCOS.
Laparoscopic ovarian drilling is a surgical procedure in which small areas of ovarian tissue are treated using controlled energy to influence ovarian androgen production and potentially restore ovulation.
It is not a routine first-line treatment for PCOS.
It may be considered in carefully selected women with anovulatory infertility, particularly after resistance to appropriate oral ovulation-induction treatment and when no other infertility factors are present.
Potential risks include:
The 2023 international guideline recognises laparoscopic ovarian surgery as a potential second-line option in selected circumstances.
Many women with PCOS achieve pregnancy, either naturally or with fertility treatment.
However, there is no single pregnancy success rate that applies to every patient with PCOS.
The likelihood of success depends on:
Women with PCOS may produce a relatively high number of eggs during IVF stimulation, but a higher egg count does not automatically mean a higher live birth rate.
Treatment outcomes should be evaluated using age-specific and clinically relevant measures, particularly live birth rates per embryo transfer or per egg retrieval.
No verified Life Fertility Centre-specific PCOS IVF success percentage is available for inclusion here. Patients should request outcomes relevant to their age and diagnosis rather than relying on general advertising percentages.
Women with PCOS can have healthy pregnancies, but certain complications may occur more frequently, including:
Risk varies substantially between individuals.
Before conception, reviewing blood glucose, blood pressure, medications, nutritional status and other health conditions can help improve pregnancy planning.
A diagnosis of PCOS does not mean these complications will necessarily occur.
Consider a specialist consultation if your periods are persistently irregular, you are unsure whether you ovulate, or you are concerned about PCOS-related symptoms.
Earlier fertility evaluation may be particularly helpful if you have been trying to conceive without success, are aged 35 or older, have very infrequent periods or have other known reproductive concerns.
You do not always need to wait 12 months before seeking fertility advice when ovulation problems are already suspected.
MBBS, MS (Obstetrics & Gynaecology), DNB (Obstetrics & Gynaecology)
Fellowship in Reproductive Medicine | Advanced Diploma in Reproductive Medicine, Kiel, Germany
Dr. Katha Desai leads Life Fertility Centre at Nirmala Maternity & Surgical Hospital, South Mumbai.
Her specialised training in reproductive medicine, including advanced education in Germany, supports her approach to evaluating ovulatory disorders, infertility and assisted reproductive treatment.
She has contributed to FOGSI clinical manuals and is an active member of the Mumbai Obstetric & Gynaecological Society (MOGS).
Her clinical approach emphasises understanding each patient's hormonal and reproductive health, identifying contributing fertility factors and developing an individualised treatment plan.
For women with PCOS, this means considering both fertility goals and broader metabolic health rather than focusing on ovarian ultrasound findings alone.
Treatment planning considers menstrual history, hormonal findings, metabolic risk factors and reproductive goals.
Not every woman with PCOS needs IVF. When appropriate, treatment may begin with lifestyle support and ovulation induction before considering more advanced options.
Both partners' reproductive health can be evaluated to identify additional factors that may affect conception.
Treatment recommendations are informed by recognised clinical guidelines, individual circumstances and careful discussion of risks and benefits.
Life Fertility Centre at Nirmala Maternity & Surgical Hospital offers a convenient location for patients seeking PCOS fertility consultation in South Mumbai.
The cost of PCOS treatment in Mumbai varies according to the investigations required, medication, monitoring and whether assisted reproductive treatment is necessary.
Some patients need only clinical assessment and ongoing metabolic management, while others require ovulation induction, IUI or IVF.
| Treatment component | What may be included |
|---|---|
| Initial PCOS consultation | Medical history, symptom review and treatment planning |
| Hormonal and metabolic evaluation | Selected blood tests, glucose assessment and ultrasound |
| Lifestyle and medical management | Nutrition guidance, follow-up and prescribed medication |
| Ovulation induction | Medication and follicular ultrasound monitoring |
| IUI | Ovulation monitoring, sperm preparation and insemination |
| IVF / ICSI | Ovarian stimulation, egg retrieval, laboratory procedures and embryo transfer |
| Frozen embryo transfer | Embryo warming, endometrial preparation and transfer |
| Laparoscopic ovarian drilling | Surgery, anaesthesia and associated hospital charges when indicated |
Because treatment requirements vary, a fixed PCOS fertility package may not reflect the actual care needed.
For accurate PCOD treatment costs in Mumbai, request an individualised estimate from Life Fertility Centre before beginning treatment.
PCOS can affect hormonal balance, ovulation and fertility, but with appropriate diagnosis and personalised treatment, many women with PCOS can improve their chances of conceiving.
At Life Fertility Centre, Dr. Katha Desai provides individualised PCOS and fertility consultations, offering evidence-based treatment options to support your reproductive health and pregnancy goals.
Life Fertility Centre
Nirmala Maternity & Surgical Hospital, South Mumbai